These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12426865)

  • 1. [Prospective study of effectiveness. Reoperation (re-TUR) in superficial bladder carcinoma].
    Vögeli TA; Grimm MO; Simon X; Ackermann R
    Urologe A; 2002 Sep; 41(5):470-4. PubMed ID: 12426865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Cumberbatch MGK; Foerster B; Catto JWF; Kamat AM; Kassouf W; Jubber I; Shariat SF; Sylvester RJ; Gontero P
    Eur Urol; 2018 Jun; 73(6):925-933. PubMed ID: 29523366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A second transurethral resection could be not necessary in all high grade non-muscle-invasive bladder tumors].
    Gaya JM; Palou J; Cosentino M; Patiño D; Rodríguez-Faba O; Villavicencio H
    Actas Urol Esp; 2012 Oct; 36(9):539-44. PubMed ID: 22710093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?
    Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H
    J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Naselli A; Hurle R; Paparella S; Buffi NM; Lughezzani G; Lista G; Casale P; Saita A; Lazzeri M; Guazzoni G
    Eur Urol Focus; 2018 Jul; 4(4):558-567. PubMed ID: 28753839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?
    Schips L; Augustin H; Zigeuner RE; Gallé G; Habermann H; Trummer H; Pummer K; Hubmer G
    Urology; 2002 Feb; 59(2):220-3. PubMed ID: 11834389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restaging transurethral resection of bladder tumor for high-risk stage Ta and T1 bladder cancer.
    Ramírez-Backhaus M; Domínguez-Escrig J; Collado A; Rubio-Briones J; Solsona E
    Curr Urol Rep; 2012 Apr; 13(2):109-14. PubMed ID: 22367558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR.
    Orsola A; Cecchini L; Raventós CX; Trilla E; Planas J; Landolfi S; de Torres I; Morote J
    BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
    Kamiya N; Suzuki H; Suyama T; Kobayashi M; Fukasawa S; Sekita N; Mikami K; Nihei N; Naya Y; Ichikawa T
    Int J Clin Oncol; 2017 Apr; 22(2):353-358. PubMed ID: 27744487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a second transurethral resection on the staging of T1 bladder cancer.
    Dalbagni G; Herr HW; Reuter VE
    Urology; 2002 Nov; 60(5):822-4; discussion 824-5. PubMed ID: 12429307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of a second transurethral resection for T1 bladder cancer.
    Schwaibold HE; Sivalingam S; May F; Hartung R
    BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-a2b reduces neo-microvascular density in the 'normal' urothelium adjacent to the tumor after transurethral resection of superficial bladder carcinoma.
    Giannopoulos A; Adamakis I; Evangelou K; Giannopoulou M; Zacharatos P; Zsantoulis P; Perunovic B; Athanasiou A; Retalis G; Constandinidis C; Gorgoulis VG
    Onkologie; 2003 Apr; 26(2):147-52. PubMed ID: 12771523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second transurethral resection and adjuvant radiotherapy in conservative treatment of pT2N0M0 bladder tumors.
    Geavlete P; Georgescu D; Florea I
    Eur Urol; 2003 May; 43(5):499-504. PubMed ID: 12705994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory).
    Sözen S; Akbal C; Sökmensüer C; Ekici S; Ozen H
    Urol Int; 2002; 69(3):200-6. PubMed ID: 12372888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Second resection in patients with Ta-T1 bladder tumors].
    Rodríguez-Rubio Cortadellas FI; Garrido Insua S; Rivas Aguayo D; Hens Pérez A; Bachiller Burgos J; Beltrán Aguilar V; Varo Solís C; Sánchez Bernal C; Juárez Soto A; González Moreno D
    Actas Urol Esp; 2001 Sep; 25(8):553-8. PubMed ID: 11692797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second-look TUR in T1 transitional cell carcinoma: why?
    Jakse G; Algaba F; Malmström PU; Oosterlinck W
    Eur Urol; 2004 May; 45(5):539-46; discussion 546. PubMed ID: 15082193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.